The Diabetes Unit of the HM Montepríncipe University Hospital offers its patients the implementation of the subcutaneous blood glucose control sensor, called 'Eversese'.
It is a sensor that is located under the skin, which allows the possibility of being released, "allows greater freedom of movement, is more discreet and offers high reliability", as well as a complete monitoring for 90 days,which will soon be extended to 180 days thanks to the XL model, as reported by the hospital.
"Continuous monitoring allows you to know the level of blood glucose 24 hours a day. Permanent readings make the system use the data to predict the trend of glucose level and show that information to an app to help decision makingOn the part of the patient.
The sensor is a biocompatible capsule that is introduced into the arm with a simple intervention in consultation, and that unlike other systems, uses a glucose measurement system based on fluorescence.
On the other hand, 'Eversese' has an intelligent, removable, rechargeable and water resistant transmitter that is placed on the sensor to save glucose values and send them via Bluetooth to an app installed on the patient's mobile phone, which offers accessIn real time to glucose measurements.
"In this way, it allows to establish predictive alerts, monitor meals and exercise, visualize historical reports and identify trends through simple graphics to interpret and that can be shared with the healthcare professional. In fact, it facilitates control of diabetes mellitusimpacting the prevention of complications, "the doctor continued.
In addition, the sensor "is indicated for all those patients with diabetes mellitus who want to improve their glycemic control and reduce the risk factors that may appear because of this disease," said Dr. García Durruti.
